Brief: Mei Pharma Issued Letter To Shareholders Reiterating Board Of Directors Recommendation To Vote For Pending Transaction With Infinity Pharmaceuticals
29/06/2023 13:18
June 29 (Reuters) - MEI Pharma Inc MEIP.O :
* MEI PHARMA - ISSUED LETTER TO SHAREHOLDERS REITERATING
BOARD OF
DIRECTORS RECOMMENDATION TO VOTE FOR PENDING TRANSACTION WITH
INFINITY PHARMACEUTICALS
Source text for Eikon: ID:nBwbbhmbta
Further company coverage: MEIP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations